The vaccine is the best way to protect yourself against serious illness and hospitalisation from Covid-19. That’s why people at higher risk, such as older people and those with certain health ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2025 sales and earnings conference call with institutional ...

Approves Merck’s CAPVAXIVE® for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults Business Wire • 8 days ago Merck Enters Exclusive License Agreement for HRS-5346, an ...

Merck & Co has joined with the non-profit scientific research organisation, the International AIDS Vaccine Initiative (IAVI), to develop a potential vaccine against the SARS-CoV-2 coronavirus that ...

WuXi Vaccines, a wholly-owned subsidiary of China’s contract development and manufacturing organization (CDMO) WuXi Biologics (HKEX: 2269), today announced a definitive agreement with Merck & Co’s ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Vaxcyte, Inc. (NASDAQ:PCVX) stands against the other best mid cap ...

The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...

Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for active immunization for ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Health officials prepare to administer a vaccine ...